Inter and intra laboratory concordance of HLA antibody results obtained by single antigen bead based assay

Human Immunology

Volumn 74, Issue 3, 2013, Pages 310-317

  Gandhi, Manish J ^a   DeGoey, Steven ^a   Falbo, Deborah ^a   Jenkins, Sarah ^a   Stubbs, James R ^a   Noreen, Harriet ^b   Lorentzen, David F ^c   Lee, JarHow ^d   Stegall, Mark ^a  

^a MAYO CLINIC   (United States)

^b UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^c University of Wisconsin Health   (United States)

^d Thermo Fisher Scientific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY;

ARTICLE; CLINICAL PROTOCOL; COMPARATIVE STUDY; CORRELATION COEFFICIENT; HUMAN; IMMUNOASSAY; LABORATORY TEST; PRIORITY JOURNAL; SINGLE ANTIGEN BEAD BASED ASSAY;

ANTIBODIES; ANTIBODY SPECIFICITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOLOGIC TECHNIQUES; LABORATORIES; MICROSPHERES; REPRODUCIBILITY OF RESULTS;

EID: 84873715740     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.003     Document Type: Article

References (28)

1. Amico P, Hirt-Minkowski P, Honger G, Gurke L, Mihatsch MJ, Steiger J, Hopfer H, Schaub S: Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations. Transpl Int 24(6):560.
2. Amico P., Honger G., Mayr M., Steiger J., Hopfer H., Schaub S. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009, 87(11):1681.
3. Gandhi M.J., DeGoey S.R., Bundy K., Kremers W.K., Knauer R., Pereira N., et al. Effect of pretransplant human leukocyte antigen antibodies detected by solid-phase assay on heart transplant outcomes. Transplant Proc 2011, 43(10):3840.
4. Gloor J.M., Winters J.L., Cornell L.D., Fix L.A., DeGoey S.R., Knauer R.M., et al. Baseline donor-specific antibody levels and outcomes in positive crossmatch kidney transplantation. Am J Transplant 2010, 10(3):582.
5. Amico P., Honger G., Steiger J., Schaub S. Utility of the virtual crossmatch in solid organ transplantation. Curr Opin Organ Transplant 2009, 14(6):656.
6. Lefaucheur C., Loupy A., Hill G.S., Andrade J., Nochy D., Antoine C., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21(8):1398.
7. Taner T., Gandhi M.J., Sanderson S.O., Poterucha C.R., De Goey S.R., Stegall M.D., et al. Prevalence, course and impact of HLA donor-specific antibodies in liver transplantation in the first year. Am J Transplant 2012, 12(6):1504.
8. Cosio F.G., Gloor J.M., Sethi S., Stegall M.D. Transplant glomerulopathy. Am J Transplant 2008, 8(3):492.
9. Gaston R.S., Cecka J.M., Kasiske B.L., Fieberg A.M., Leduc R., Cosio F.C., et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010, 90(1):68.
10. Hidalgo L.G., Campbell P.M., Sis B., Einecke G., Mengel M., Chang J., et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009, 9(11):2532.
11. Wiebe C., Gibson I.W., Blydt-Hansen T.D., Karpinski M., Ho J., Storsley L.J., et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012, 12(5):1157.
12. Gupta A., Sinnott P. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies in renal patients waiting for a transplant: a risk factor. Hum Immunol 2009, 70(8):618.
13. van den Berg-Loonen E.M., Billen E.V., Voorter C.E., van Heurn L.W., Claas F.H., van Hooff J.P., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008, 85(8):1086.
14. Murphey C.L., Bingaman A.W. Histocompatibility considerations for kidney paired donor exchange programs. Curr Opin Organ Transplant 2012, 17(4):427.
15. Cecka J.M. Current methodologies for detecting sensitization to HLA antigens. Curr Opin Organ Transplant 2011, 16(4):398.
16. Archdeacon P., Chan M., Neuland C., Velidedeoglu E., Meyer J., Tracy L., et al. Summary of FDA antibody-mediated rejection workshop. Am J Transplant 2011, 11(5):896.
17. Tait B.D., Hudson F., Brewin G., Cantwell L., Holdsworth R. Solid phase HLA antibody detection technology-challenges in interpretation. Tissue Antigens 2010, 76(2):87.
18. Zachary A.A., Sholander J.T., Houp J.A., Leffell M.S. Using real data for a virtual crossmatch. Hum Immunol 2009, 70(8):574.
19. Aubert V., Venetz J.P., Pantaleo G., Pascual M. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant. Hum Immunol 2009, 70(8):580.
20. Susal C., Ovens J., Mahmoud K., Dohler B., Scherer S., Ruhenstroth A., et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive luminex single-antigen testing: a collaborative transplant study report. Transplantation 2011, 91(8):883.
21. Bray R.A., Gebel H.M. Strategies for human leukocyte antigen antibody detection. Curr Opin Organ Transplant 2009, 14(4):392.
22. Jacob E.K., De Goey S.R., Gandhi M.J. Positive virtual crossmatch with negative flow crossmatch results in two cases. Transpl Immunol 2011, 25(1):77.
23. Pereira S., Perkins S., Lee J.H., Shumway W., LeFor W., Lopez-Cepero M., et al. Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?. Hum Immunol 2011, 72(6):492.
24. Zoet Y.M., Brand-Schaaf S.H., Roelen D.L., Mulder A., Claas F.H., Doxiadis I.I. Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations?. Tissue Antigens 2011, 77(3):225.
25. Zachary A.A., Lucas D.P., Detrick B., Leffell M.S. Naturally occurring interference in luminex assays for HLA-specific antibodies: characteristics and resolution. Hum Immunol 2009, 70(7):496.
26. Schnaidt M., Weinstock C., Jurisic M., Schmid-Horch B., Ender A., Wernet D. HLA antibody specification using single-antigen beads-a technical solution for the prozone effect. Transplantation 2011, 92(5):510.
27. Liu C., Wetter L., Pang S., Phelan D.L., Mohanakumar T., Morris G.P. Cutoff values and data handling for solid-phase testing for antibodies to HLA: effects on listing unacceptable antigens for thoracic organ transplantation. Hum Immunol 2012, 73(6):597.
28. Tambur A.R., Ramon D.S., Kaufman D.B., Friedewald J., Luo X., Ho B., et al. Perception versus reality?: virtual crossmatch-how to overcome some of the technical and logistic limitations. Am J Transplant 2009, 9(8):1886.